When exploring the structural components of proteins, the EGF peptide sequence stands out as a fundamental subject for researchers and enthusiasts of biochemistry. As someone who has spent significant time reviewing technical documentation and protein databases, I have found that understanding the specific architecture of this molecule is essential for grasping how it functions within various biological models.
Defining the EGF Structure
At its core, Human EGF is a 6-kDa protein with 53 amino acid residues and three critical intramolecular disulfide bonds. These bonds are vital for maintaining the structural integrity of the protein. When we discuss the EGF, epidermal growth factor, we are looking at a highly conserved molecule that plays a pivotal role in the epidermal growth factor family.
From my personal review of laboratory data, it is fascinating how this protein is processed. The mature EGF (53 amino acid residues) is generated through the proteolytic processing of a much larger preproprotein. In fact, the EGF is synthesized as a large protein precursor of 1,168 amino acids, which highlights the complex nature of its biosynthesis.
Technical Specifications and Sequence Analysis
For those interested in the sequence, the primary structure is well-documented. The amino acid sequence starts with a highly specific configuration: *Met-Asn-Ser-Asp-S EGF chain, domains I, II, III, and IVin the EGFR receptor are colored cyan, yellow, pink, red, and silver, respectively. (C) Amino acid sequence of hEGF.Read more er-Glu-Cys-Pro-Leu-Ser-His-Asp-Gly-Tyr-Cys*. This sequence is identical in amin EGF Family o acid sequence to the naturally occurring peptide found in many biological systems.
Key technical insights regarding the EGF gene and its products include:
* Molecular Weight: The protein is approximately 6-kDa.
* Genomic Context: The EGF gene / cDNA is a protein-coding gene located on chromosome 4q25.
* Domain Structure: Structural analysis reveals the EGF chain, domains I, II, III, and IV within the receptor complex, which are critical for its inter A PEPTIDE SEQUENCE FROM THE EGF-2 LIKE DOMAIN action capacity.
* Variants: Research indicates the EGF-BP has been separated into two sequence variants, types A and B, demonstrating the diversity within this protein class.
Comparative Analysis and Variations
In my experience, comparing different forms of this peptide helps clarify its function. For instance, LONG® EGF is a specialized variant that comprises the human EGF amino acid sequence plus an additional 53-amino acid N-te by A Gray·1983·Cited by 699—Here we present the sequence of a mouse EGF cDNA clone, which suggests thatEGF is synthesized as a large protein precursor of 1,168 amino acidsRead more rminal extension. This modification is frequently discussed in literature related to cell culture applications.
Furthermore, scientists often examine the EGF domain (317-355) to understand how motifs contribute to the protein's activity. Whether analyzing the EGFRp4 peptide or standard recombinant forms, the consistency of the EGF sequence remains a benchmark in structural biology.
Why Sequence Accuracy Matters
When reviewing materials, I always emphasize the importance of verified It comprises thehuman EGF amino acid sequenceplus a 53 amino acid N-terminal extension peptide. LONG®EGF has applications in MSC, iPS, epithelial, Read more sequences. Whether you are looking at the Oligopeptide nomenclature (sometimes labeled as rh-Oligopeptide-1) or studying the Epidermal Growth Factor receptor interactions, the precision of the 53-amino acid chain is what dictates its biological efficacy.
By grounding our understanding in the human EGF is 6-kDa specification and the verified amino acid sequence, we can better appreciate the intricate design of this molecule. While the EGF gene provides the blueprint, the actual folding and disulfide bond formation represent the true functional state of this remarkable protein. Through careful study of EGF Gene - Epidermal Growth Factor these sequences, we gain a deeper appreciation for the molecular mechan 1950 - Gene ResultEGF epidermal growth factor [ (human)] isms that govern cellular signaling pathways.